Literature DB >> 3556996

Prospective study of the ability of computed axial tomography to localize gastrinomas in patients with Zollinger-Ellison syndrome.

S A Wank, J L Doppman, D L Miller, M J Collen, P N Maton, R Vinayek, J I Slaff, J A Norton, J D Gardner, R T Jensen.   

Abstract

The ability of routine computed tomography (CT) performed with oral and intravenous contrast to localize gastrinomas in 61 consecutive patients with Zollinger-Ellison syndrome was evaluated prospectively. The results of CT scanning were subsequently evaluated in all patients by either surgery, autopsy, or percutaneous biopsy. Thirteen of 14 patients with CT scans positive for hepatic metastases and 5 of 13 patients with CT scans negative for hepatic metastases were found to have gastrinoma in the liver. For gastrinoma metastatic to the liver, CT scanning had a specificity of 98%, a sensitivity of 72%, a positive predictive value of 93%, and a negative predictive value of 90%. Twenty-two of 23 patients with positive extrahepatic CT scans and 15 of 33 patients with negative extrahepatic CT scans were found to have extrahepatic gastrinomas. For extrahepatic gastrinoma, CT scanning had a specificity of 95%, a sensitivity of 59%, a positive predictive value of 96%, and a negative predictive value of 54%. The ability of CT scan to detect gastrinomas both in the liver and extrahepatically was directly related to tumor size, detecting 0% of tumors less than 1 cm and 83%-95% of tumors greater than 3 cm. The location of the extrahepatic gastrinoma was also an important determinant in that approximately 80% of pancreatic gastrinomas but only 35% of extrapancreatic gastrinomas were detected. The present results indicate that because of its convenience and accuracy, CT scanning with oral and intravenous contrast material should be the initial procedure to evaluate the extent of gastrinoma. A positive CT scan is almost always correct; therefore, a CT scan detecting metastatic gastrinoma to the liver would avoid unnecessary surgery and, if positive for extrahepatic gastrinoma, would assist the surgeon in finding the gastrinoma. A negative CT is less reliable; therefore, patients should undergo other localizing studies before exploratory laparotomy.

Entities:  

Mesh:

Year:  1987        PMID: 3556996     DOI: 10.1016/0016-5085(87)90963-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  26 in total

Review 1.  Catching the Zebra: Clinical Pearls and Pitfalls for the Successful Diagnosis of Zollinger-Ellison Syndrome.

Authors:  Aaron H Mendelson; Mark Donowitz
Journal:  Dig Dis Sci       Date:  2017-08-03       Impact factor: 3.199

2.  Intraoperative ultrasonographic localization of islet cell tumors. A prospective comparison to palpation.

Authors:  J A Norton; D T Cromack; T H Shawker; J L Doppman; R Comi; P Gorden; P N Maton; J D Gardner; R T Jensen
Journal:  Ann Surg       Date:  1988-02       Impact factor: 12.969

Review 3.  Unresolved surgical issues in the management of patients with Zollinger-Ellison syndrome.

Authors:  J A Norton; R T Jensen
Journal:  World J Surg       Date:  1991 Jan-Feb       Impact factor: 3.352

4.  Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.

Authors:  H R Alexander; D L Fraker; J A Norton; D L Bartlett; L Tio; S B Benjamin; J L Doppman; S U Goebel; J Serrano; F Gibril; R T Jensen
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

5.  Management and outcome of patients with sporadic gastrinoma arising in the duodenum.

Authors:  Theresa G Zogakis; Fathia Gibril; Steven K Libutti; Jeffrey A Norton; Donald E White; Robert T Jensen; H Richard Alexander
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

6.  Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors.

Authors:  Matthias Banasch; Frank Schmitz
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

7.  The Zollinger-Ellison syndrome. A collective surgical experience.

Authors:  D R Farley; J A van Heerden; C S Grant; L J Miller; D M Ilstrup
Journal:  Ann Surg       Date:  1992-06       Impact factor: 12.969

8.  Localisation of neuroendocrine tumours of the upper gastrointestinal tract.

Authors:  T Zimmer; K Ziegler; M Bäder; U Fett; B Hamm; E O Riecken; B Wiedenmann
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

9.  Gastrinoma excision for cure. A prospective analysis.

Authors:  T J Howard; M J Zinner; B E Stabile; E Passaro
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

10.  Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study.

Authors:  J A Norton; J L Doppman; R T Jensen
Journal:  Ann Surg       Date:  1992-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.